in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—4 February 2014
7:09 AM MST | February 4, 2014 | Deepti Ramesh
Johnson Matthey appoints new CEO, fine chemicals sales up Johnson Matthey announced the appointment of its new CEO and reported the third-quarter results, covering 1 October 2013 through 29 January 2014. Robert MacLeod will succeed Neil Carson as CEO when Carson steps down following the group’s annual results on 5 June. Carson will remain on the board until end of September, when he is due to retire. Johnson Matthey's fine chemicals’ sales were up 7%, to £76 million ($124 million), and operating profit was well ahead of last year’s...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee